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Department of Medicine, University of Ghana Medical School, PO Box 4236, Accra, Ghana 
This study assessed first-year doctors’ (House Officers) knowledge of asthma at the Korle-Bu Teaching 
Hospital. Seventy-two out of 80 doctors answered 32 questions on various aspects of asthma. Many of these 
doctors managed between one to three asthmatics per week. Few, however, did so by acceptable standards. In 
assessing the severity of asthma, 88% looked for cyanosis, 69% looked for pulsus paradoxicus and 63% looked 
for a fast pulse rate. Only 63% considered the measurement of peak expiratory flow useful. Ninety-four per 
cent used intravenous aminophylline, 82% intravenous hydrocortisone and 14% oxygen as the drug of choice 
for acute severe asthma. In moderate forms of acute asthma, 54% used salbutamol inhaler or intravenous 
aminophylline, 28% oxygen, 15% steroid inhaler and 14% oral prednisolone. Nebulized bronchodilators are 
not well known for use in either severe or moderate asthma and only 19-21% of doctors had prescribed their 
use. In chronic asthma, 55565% of respondents prescribed bronchodilators compared to 19-35% who gave 
anti-inflammatory drugs. These results reveal insufficient knowledge of the pathophysiology of asthma, the use 
of standard drugs in asthma therapy and international guidelines for the management of asthma. The results 
also show that the pragmatic constraints which exist in developing countries preclude the adoption of 
international guidelines without local modification. 
Introduction 
Asthma is now recognized to be due to chronic 
inflammation of the airways. There is evidence of 
inflammation even in patients with mild forms of the 
disease (1). This current view of the pathophysiology 
of the disease has altered the traditional methods 
of management. Internationally, the rationale of 
management is primarily to reduce inflammation. 
Anti-inflammatory drugs are generally preferred to 
bronchodilators in modern practice (2). 
The disease still has a significant morbidity and 
mortality which may increase worldwide despite the 
availability of potent drugs. Among the major factors 
which contribute to the morbidity and mortality of 
asthma are under-diagnosis and under-treatment by 
medical personnel and patients (3-5). Factors related 
to the availability of health care are also major 
contributors (6,7). In Third World countries where 
hospital facilities are inadequate and where current 
information about management may not be readily 
available, morbidity and mortality are expected to be 
even higher. Lack of knowledge of the pathophysiol- 
ogy of asthma has also contributed to the morbidity 
and mortality of the disease. To reduce mortality and 
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morbidity of asthma in developing countries in par- 
ticular, education of health personnel and even of 
patients on principles of the management of asthma 
is essential (8). This need has, indeed, been empha- 
sized in the international guidelines for assessment 
and treatment of asthma (2). 
In Ghana, bronchial asthma is well known and 
commonly encountered in clinical practice. However, 
very little systematic work has been done to establish 
its prevalence and the level of mortality. It is also 
important to determine the level of knowledge of 
practising doctors in Ghana of the disease and its 
management. The present study focuses on recently 
qualified doctors who, presumably, have current 
knowledge of the management of asthma from recent 
medical school training. A reason for choosing this 
group is that House Officers are first-in-line for the 
management of emergencies including asthma. Man- 
agement problems are more likely to be associated 
with this group. 
Methods 
Seventy-two out of 80 House Officers (aged 25-32 
years) at the Korle-Bu Teaching Hospital (KBTH) in 
Accra participated in this study. KBTH is the pri- 
mary referral centre in Ghana. It has a bed capacity 
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of 1700, and is the main hospital for training students 
from the University of Ghana Medical School. 
House Officers involved in this study had worked in 
the KBTH for up to 12 months after graduation from 
medical school. They included doctors trained at the 
University of Ghana Medical School, the School of 
Medical Sciences, Kumasi and a number from 
schools outside Ghana. 
Table 1 Drugs which House Officers would use in the 
management of acute asthmatic attack 
No. (“36) of House Officers 
Moderate 
asthma 
Severe 
asthma 
Each respondent answered 32 questions on various 
aspects of asthma, including its management. Some 
of the questions demanded multiple responses to 
determine degree of knowledge. The areas surveyed 
included 
1. experience with the management of asthma; 
2. assessing the severity of asthma; 
3. choice of drugs for managing acute and chronic 
asthma; 
4. knowledge of the effectiveness of drugs commonly 
Salbutamol inhaler 
Aminophylline injection 
Fran01 tablets 
Oxygen 
Hydrocortisone injection 
Nebulized bronchodilators 
Aminophylline tablets 
Steroid inhaler 
Prednisolone tablets 
Adrenaline injection (1:lOOO) 
Salbutamol tablets 
Salbutamol injection 
Others 
39 (54) 17 (24) 
39 (54) 68 (94) 
26 (36) 5 (7) 
20 (28) 53 (74) 
12 (17) 59 (82) 
15 (21) 21 (29) 
9 (13) 1 (1) 
11 (15) 6 (8) 
10 (14) 18 (25) 
8 (11) 17 (24) 
7 (10) 2 (3) 
4 (6) 8 (11) 
3 (4) 6 (8) 
used; 
5. the use of analgesics, sedatives and tranquillizers 
for asthma; 
6. knowledge of nebulized bronchodilators. 
Table 2 Drugs which House Officers would use in the 
maintenance treatment of chronic asthma 
The results were analysed and expressed as num- 
bers or percentages of those who responded. No. (%) of House Officers 
Results 
EXPERIENCE WITH THE MANAGEMENT OF ASTHMA 
During the 3 month study, 51% of House Officers 
managed one to three asthmatics a month, 25% 
between one to three per week and 24% had no 
experience of the management of asthma. Of those 
who had managed patients with asthma, 82% were 
satisfied with the results of their management, 11% 
were not sure and 7% were unhappy. 
Salbutamol tablets 
Salbutamol inhaler 
Fran01 
Ketotifen 
Prednisolone 
Aminophylline tablets 
Steroid inhaler 
Others 
47 (65) 
46 (64) 
39 (55) 
25 (35) 
21 (29) 
16 (22) 
14 (19) 
16 (22) 
ASSESSING THEI SEVERITY OF ASTHMA 
severe acute asthma. House Officers seldom used 
oxygen for mild-to-moderate acute asthma, and not 
all used it for severe asthma. 
In assessing the severity of asthma, 88% of House 
Officers looked for cyanosis, 69% for pulsus para- 
doxicus, 63% for a rapid pulse rate, 60% for difficulty 
in talking, eating and walking, 36% for the degree of 
anxiety of the patient, 25% for the intensity of wheeze 
and 57% elicited history regarding the duration of the 
attack. Only 63% indicated they used peak expiration 
flow to determine the severity of asthma. 
If the patient failed to improve after initial man- 
agement, 46% of House Officers referred them to a 
specialist, 33% increased the dose of the first-line 
drug, 14% continued management as before and 8% 
added steroids if these were not used initially. Ten per 
cent of respondents did not know what to do next for 
such patients. 
DRUGS USED FOR MANAGING ACUTE ASTHMA 
DRUGS USED FOR THE CONTINUING MANAGEMENT OF 
ASTHMA 
The results are summarized in Table 1. Bronchodi- The choice of drugs for the continuing manage- 
lators were the most popular drugs used for both ment of asthma is shown in Table 2. Bronchodilators 
mild-to-moderate and severe asthma; 36% would were again more popular than anti-inflammatory 
even consider prescribing Franol, a drug which 63% agents. As many as 44% of House Officers continued 
knew contained ephedrine and theophylline, and only with bronchodilators for patients whose asthma 
43% knew contained phenobarbitone. Steroids, espe- attacks became more frequent, while 21% were not 
cially by inhalation, were least popular, except for sure what to do for such individuals. 
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Table 3 House Officers’ choice of drugs for acute asthma 
which they considered to be most effective with minimal 
side-effects 
No. (“VI) of House Officers 
Hydrocortisone injection 29 (40) 
Prednisolone tablets 5 (7) 
Aminophylline injection 41 (66) 
Salbutamol inhaler 19 (26) 
Fran01 tablets 4 (6) 
Salbutamol tablets 5 (7) 
Adrenaline (1: 1000) injection 9 (12) 
Aminophylline tablets 0 (0) 
Steroid inhaler 6 (8) 
Nebulized salbutamol 26 (36) 
Salbutamol injection 1 (1) 
Theophylline injection 3 (4) 
DRUGS CONSIDERED MOST EFFECTIVE AND WITH 
MINIMAL SIDE-EFFECTS 
These are shown in Table 3. Aminophylline (iv) 
was considered the drug of choice followed by hydro- 
cortisone (iv), nebulized salbutamol and salbutamol 
inhaler. Although 44% of House Officers knew that 
steroid inhalers were available in Ghana, only 8% 
considered them to be effective and to have only 
minimal side-effects. Ninety-two per cent knew of the 
availability of salbutamol inhaler in Ghana but only 
26% indicated that it was effective and safe. In 
contrast, 90% of those who used nebulized salbuta- 
mol considered it effective and safe, compared with 
67% of those who used aminophylline (iv). 
USE OF ANALGESICS, SEDATIVES AND TRANQUILLIZERS 
FOR MANAGING ACUTE ASTHMA 
Forty-six per cent of House Officers did not give 
any form of analgesic, sedative or tranquillizer for 
the management of acute and severe asthma. Twenty- 
three per cent gave diazepam and 11% phenobarbi- 
tone. Eighteen per cent were not certain whether to 
use these drugs or not. One person indicated recourse 
to pethidine and another to chlorpromazine for the 
treatment of severe asthma. The drugs named were 
administered for various reasons including allevia- 
tion of anxiety, direct treatment of asthma, induction 
of sleep and relaxation of the patient. Twenty-eight 
per cent of those who gave such drugs did not 
indicate the rationale for their use. 
NEBULIZATION OF BRONCHODILATORS 
Seventy-one per cent of House Officers indicated 
that nebulization of P-adrenergic agonists was effec- 
tive in the treatment of asthma, 28% did not know 
what this was, 69% thought nebulization did not 
require expensive equipment, and 54% indicated that 
only piped oxygen was required. This is compared to 
40% who knew about the availability of nebulized 
/I-adrenergic agonists at KBTH. 
INTRAVENOUS ADMINISTRATION OF AMINOPHYLLINE 
With regard to the intravenous administration of 
aminophylline, the survey revealed the following: (i) 
24% of House Officers did not know the loading dose 
of aminophylline; (ii) 44% gave this drug at the 
dosage of 5 mg kg- ’ body weight; (iii) 76% gave an 
initial dose of 250 mg in an adult; and (iv) 32% did 
not know the recommended duration for injection of 
the loading dose - 3% injected the loading dose over 
5 min, 56% over 10 min and 10% did so over 20 min. 
Thirty-three per cent of those surveyed reduced the 
loading dose of aminophylline for patients with renal 
failure, 19% for chronic alcoholics, 15% for smokers, 
60% for patients with impairment of liver function 
and 33% for patients on oral xanthines. Approxi- 
mately half the number of House Officers (55%) did 
not know when to modify the loading dose of 
aminophylline. 
THE PEAK FLOW METER 
Thirty-three per cent of House Officers indicated 
they did not know about the peak flow meter and 7% 
thought it was expensive. Only 10% did not regard it 
as necessary for managing asthma. 
Discussion 
With reference to the international guidelines for 
the management of asthma (2), this survey reveals 
that only 25% of House Officers surveyed managed 
asthma patients properly. Fifty per cent have insufB- 
cient knowledge of asthma, and 25% have little or no 
knowledge of managing the disease. This is disturb- 
ing and probably contributes to the high morbidity 
and mortality of the disease in Ghana. It also reveals 
possible deficiencies in the basic medical training 
programme that must be addressed. 
The initial assessment of the severity of asthma is 
crucial to proper and adequate management of the 
disease and to its future course. It is worrying there- 
fore that many House Officers did not know the early 
symptoms and signs important for the proper assess- 
ment of the severity of the disease. Most would wait 
for gross and late signs, such as pulsus paradoxicus 
or cyanosis, and some would not even recognize such 
signs. Few knew about assessing the severity of the 
disease by peak expiratory flow equipment. This is 
not surprising, as this inexpensive equipment is not 
readily available in Ghana. This is therefore one of 
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the major contributory factors to the poor manage- 
ment of the disease. 
Based on the pathophysiology of the disease, 
corticosteroids are introduced early in the treatment 
of acute asthma, especially in those refractory to 
bronchodilators or with severe forms of the disease 
(2,9). From this study, most House Officers for 
instance, reserved hydrocortisone (iv) for critical 
emergencies. They also preferred hydrocortisone (iv) 
to prednisolone tablets, suggesting they did not know 
prednisolone was as effective as hydrocortisone for 
most cases of acute asthma, which is well established 
(2,lO). It is indicative of the lack of knowledge 
of the pathophysiology of the disease that many 
House Officers preferred bronchodilators to steroids. 
Another reason for this could be that House Officers 
were not aware that the effects of steroids manifest at 
least 4 h and sometimes days after administration 
(9-11). Certainly, this would explain why many did 
not describe steroid inhalers. It is also possible that 
House Officers do not prefer steroids as they are not 
aware that the short term use of systemic steroids is 
without significant long term side-effects. 
Use of aminophylline for managing acute asthma 
is still controversial. Indeed, its use within the first 4 h 
of treatment in hospital has not been recommended 
(2). Among House Officers, however, aminophylline 
was the drug of choice for severe asthma. Two 
reasons may be adduced for this. Firstly, it is likely 
that most House Officers choose this drug because 
few side-effects are known from its use locally, com- 
pared with observations elsewhere. This observation 
by itself is of research interest, suggesting genetic 
differences in response to the drug. Secondly, it is 
more readily available, relatively inexpensive and 
is recommended in the Ghana National Formulary 
(13). 
Nebulized p-adrenergic agonists which are known 
to have few side-effects and to be effective in manag- 
ing asthma were used by only a few House Officers. 
This is because they are not readily available. From 
the survey, House Officers who used them confirmed 
that they were valuable and effective. If this form of 
treatment was readily available in the hospitals, 
many more House Officers would use it and the 
management of asthma would improve even where 
knowledge of the pathophysiology of the disease is 
poor. Asthmatics would benefit greatly, as oxygen is 
also included in this method of management. It 
should be noted that most House Officers surveyed 
would not give oxygen in asthma because they did 
not appreciate that there is some level of hypoxia 
even in mild asthma. As many as 25% did not use 
oxygen even for severe asthma. 
Stepcare or stepwise approach to the therapeutic 
management of asthma is recommended in the inter- 
national guidelines (2). Fortunately, many House 
Officers follow this practice and would either increase 
the dosage of drug used or refer difficult cases to a 
specialist. This is good practice and should still be 
emphasized in the educational programme of medical 
schools in the Third World in particular. 
Although the mainstay of modern maintenance 
management of chronic asthma is with anti- 
inflammatory agents, particularly inhaled agents, 
only a minority of House Officers used such treat- 
ment. Several factors may explain this. The first is 
again the lack of knowledge of the pathophysiology 
of the disease, another reason is that anti- 
inflammatory agents known to be available in Ghana 
by the House Officers were also the ones they 
indicated were not effective or safe. Due to their 
inexperience, the House Officers were probably not 
aware of the beneficial effects of the early introduc- 
tion of inhaled corticosteroids (12). Inhaled cortico- 
steroids were not well known by the House Officers, 
while other prophylactic agents, such as sodium 
cromoglycate and nedocromil sodium, were thought 
not to be available in Ghana. The relatively higher 
cost of inhaled prophylactic agents compared with 
oral bronchodilators was also contributory to their 
low usage. 
The fact that Fran01 was commonly used under- 
scores the problem of poor knowledge of asthma and 
of the drugs available for its management. This drug, 
which is a combination of ephedrine (11 mg), theo- 
phylline (120 mg) and phenobarbitone (8 mg), is very 
popular with Ghanaian patients, not only because of 
its addictive properties but also because it is very 
cheap. In most countries the sedative component has 
been removed but this is not so for Ghana and for 
many other developing countries. The drug is still 
popular with House Officers though nearly all did not 
think highly of it. The data clearly showed that the 
danger of sedation in asthma is not recognized by a 
significant majority. 
The problems raised by the results of this survey 
are considerable. Since these doctors received medical 
education in many parts of the world, the deficiencies 
found may be more widespread than this study 
indicated. There is firstly a great need for adequate 
education of newly-qualified doctors on asthma and 
its management. Here, the international guidelines 
in the management of asthma should be stressed. 
Secondly, teaching hospitals should have the essential 
equipment for managing asthma adequately. This 
should help inculcate good practice in House Officers 
for their future contribution to asthma health 
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education and care. Thirdly, in Third World coun- 
tries, where financial resources are scarce, drugs 
imported or manufactured for asthma should be 
limited to those which are effective, inexpensive and 
have minimal side-effects. Lastly, the wide variation 
in the practices of these doctors indicates a need for 
guidelines for asthma management in developing 
countries such as Ghana. These guidelines should 
take cognizance of local circumstances, such as drug 
availability, cost and any variability in the response 
to various drugs. 
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